{"id":"NCT00309244","sponsor":"Mannkind Corporation","briefTitle":"Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up","officialTitle":"A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere /Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2008-08","completion":"2008-09","firstPosted":"2006-03-31","resultsPosted":"2014-10-16","lastUpdate":"2014-10-16"},"enrollment":677,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Diabetes Type 2"],"interventions":[{"type":"DRUG","name":"TechnosphereÂ® Insulin Inhalation Powder","otherNames":[]},{"type":"DRUG","name":"70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)","otherNames":[]}],"arms":[{"label":"TI + Insulin glargine","type":"EXPERIMENTAL"},{"label":"BPR 70/30","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this 13 month study (12 month treatment period and 1 month follow-up period) is to determine whether inhaled insulin is safe and effective in the treatment of type 2 diabetes.","primaryOutcome":{"measure":"Change From Baseline in HbA1c to Week 52","timeFrame":"Baseline to Week 52","effectByArm":[{"arm":"TI + Insulin Glargine","deltaMin":-0.59,"sd":0.063},{"arm":"BPR 70/30","deltaMin":-0.71,"sd":0.061}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":23},"locations":{"siteCount":151,"countries":["United States","Argentina","Brazil","Canada","Chile","Mexico","Poland","Russia","Spain","United Kingdom"]},"refs":{"pmids":["21999640","20609970"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":37,"n":323},"commonTop":["Hypoglycaemia","Cough","Upper respiratory tract infection","Nasopharyngitis","Influenza"]}}